Powering Precision Medicine with Unified Patient and Channel Data

Many manufacturers’ drug portfolios are shifting from primary care with large patient populations to precision medicines targeting specific patient genomes and populations. Consequently they are adopting more complex and hybrid channel strategies, incorporating both traditional retail as well as specialty pharmacy and, increasingly, “buy-and-build” strategies.

Learn how a fast-growing manufacturer of precision medicines leveraged a unified patient and channel data solution to realize improved channel performance and create a common platform for all future launches, regardless of network design or complexity. Download below!